(Dec 11th, 2024) The Paradigm Shift from Normoxia to Physoxia: Enhancing Experimental Precision for Better Translational Outcomes
The Paradigm Shift from Normoxia to Physoxia: Enhancing Experimental Precision for Better Translational
MycoFog™ is a novel system designed specifically to help tissue and cell culture labs eliminate or reduce contamination events. In this webinar we will describe the details on the use of MycoFog™ in the laboratory.
Previously we have described in general incubator/isolator contaminations and where MycoFog™ fits in the laboratory’s contamination control program. In this webinar we will describe the preventative use of MycoFog™ in detail
Learning objectives for the attendees:
Date: November 13th, 2024
Time: 11:00am EST
Randy Engler is a biotechnology business executive with years of global business development, product development and sales experience in all aspects of the biotechnology industry. With academic training in microbiology and immunology, he has led commercialization efforts and teams introducing new products and technologies to new markets, for companies as diverse as Genzyme Diagnostics to Thermo Fisher.
Randy’s global experience in research and diagnostic markets, drug delivery and therapeutic development, combined with educational accomplishments (BS, MBA) gives him strategic view of all aspects of the biotechnology industry and he brings capability and vision to MycoFog.
The Paradigm Shift from Normoxia to Physoxia: Enhancing Experimental Precision for Better Translational
(November 14, 2024) NIR-II Fluorescence imaging: Why, When and How Short-Wave Infrared (SWIR)
(November 13, 2024) Reduce and Prevent Contamination in Tissue and Cell Culture Laboratories
(October 2, 2024) Next Generation Bioprinting Platform: A Multimodal Approach for Bioprinting of
(September 18, 2024) Gamma Eye calibration, system characterization, and in vivo imaging of
(July 24, 2024) Webinar: Lab Incubator Decontamination: Why, When and How Laboratory incubators